Equibles does not estimate personal net worth.
Get an email with a short summary when Opko Health, Inc. publishes a filing, an earnings call transcript or a press release.
Get OPK alertsAdam Logal is recorded as CFO at Opko Health, Inc. (OPK). The newest filing on record that lists Adam Logal as CFO at Opko Health, Inc. (OPK) is dated April 30, 2026. The proxy statement of Opko Health, Inc. reports total compensation of $1,902,100 for Adam Logal in fiscal 2021, including a base salary of $700,000. Disclosed compensation is on record for 5 fiscal years. Adam Logal has spoken on 27 earnings calls across 1 company, most recently for Opko Health, Inc. on November 4, 2026. Opko Health, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Opko Health, Inc. includes Phillip Frost (CEO), Elias Zerhouni, M.D. (Chairman), OPKO Health (Chairman) and 7 others.
“As both Phil and Elias mentioned, the LabCorp agreement was announced on October 15th and is a defining step for Outlook. I'll start with the deal terms, then explain what it means for how we report our results.”
“We ended the quarter with a strong cash position with over $300 million in cash, cash equivalents, and restricted cash, which is more than sufficient to fund our ongoing operations and development plans while continuing to return capital to our shareholders through our share buyback program.”
“We ended the quarter with a strong cash position with over $341 million in cash, cash equivalents, and restricted cash, which is more than sufficient to fund our ongoing operating needs and development plans while we also are returning capital to our shareholders.”
“Capital allocation remains our top priority as we ended the quarter with $369 million in cash and cash equivalents and restricted cash, which is more than sufficient to fund our ongoing operations and development plans while we also returned capital to our shareholders.”
“We ended the third quarter with over $428 million in cash, cash equivalents, and restricted cash, more than sufficient to fund our ongoing operations and development plans.”
Start not stated–present
Last confirmed April 30, 2026
Diagnostics & Research · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Opko Health, Inc. (OPK) | Senior Vice President and Chief Financial Officer | $700,000 | $1,902,100 |
| 2020 | Opko Health, Inc. (OPK) | Senior Vice President and Chief Financial Officer | $600,000 | $1,552,200 |
| 2019 | Opko Health, Inc. (OPK) | Senior Vice President and Chief Financial Officer | $600,000 | $921,200 |
| 2018 | Opko Health, Inc. (OPK) | Senior Vice President and Chief Financial Officer | $600,000 | $1,250,000 |
| 2017 | Opko Health, Inc. (OPK) | Senior Vice President and Chief Financial Officer | $600,000 | $610,800 |
